Open in App
  • Local
  • U.S.
  • Election
  • Politics
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • New York Post

    WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy

    By Ariel Zilber,

    1 days ago

    https://img.particlenews.com/image.php?url=3yzJ8o_0vmH4jnl00

    WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy .

    Sistani pushed the 61-year-old company — famous for in-person meetings and portion control — to buy a telehealth platform that connected patients with doctors who can prescribe the popular obesity medications.

    However WeightWatchers’ shares have been in freefall, plummeting more than 90% this year.

    https://img.particlenews.com/image.php?url=0K9oUT_0vmH4jnl00
    Sima Sistani is out as CEO of WW International. WW International, Inc.

    The stock was down nearly $3 Friday, trading below $1.

    Weight loss drugs such as Ozempic, Wegovy could spell trouble for the diet industry

    Before the COVID pandemic, and the explosion in weight-loss drugs, the stock reached a peak of more than $44.

    Tara Comonte, a board member who previously served as president of Shake Shack, has been tapped as interim CEO while the company mulls a full-time replacement.

    Former talk show queen and WeightWatchers board member Oprah Winfrey announced earlier this year that she was leaving the company’s board after she began taking weight-loss medications.

    Oprah Winfrey resigned from WeightWatchers board because of ‘conflict of interest’

    Sistani, 61, sought to capitalize on the craze surrounding the weight loss drugs.

    https://img.particlenews.com/image.php?url=4DDMpM_0vmH4jnl00
    WeightWatchers is a brand that offers weight management services based on holistic approaches. REUTERS

    Under her leadership, WeightWatchers acquired Sequence, which has since been rebranded as WeightWatchers Clinic.

    The telehealth clinic allowed the company to begin dispensing GLP-1 drugs in addition to its traditional menu of behavioral change programs.

    CLICK HERE TO SIGN UP FOR OUR MORNING REPORT NEWSLETTER

    But competition in the telehealth sector — particularly among companies that offer versions of the GLP-1 drugs — has hindered WeightWatchers.

    https://img.particlenews.com/image.php?url=0lanEB_0vmH4jnl00
    The popularity of drugs such as Ozempic and Wegovy has had a negative impact on WeightWatchers. REUTERS

    Last month, the company cut its full-year sales target and announced it would be streamlining its business in the face of a “rapidly changing landscape.”

    The forecast cut sent the stock price down even further.

    Prior to being named CEO in 2022, Sistani was co-founder and CEO of Houseparty, a video chat app that allowed up to 8 people to join a group call at any one time.

    For top headlines, breaking news and more, visit nypost.com.

    Expand All
    Comments / 12
    Add a Comment
    Anne R
    7h ago
    Oprah helped to ruin weight wstchers.
    Virginia Tribuzio
    10h ago
    Opera made a lot money
    View all comments
    YOU MAY ALSO LIKE
    Local News newsLocal News

    Comments / 0